Immunological Data Discovery Index
Advanced Search
identifier: SDY7
description:
To measure total and specific antibody titers and T cell responses in a sample of subjects who experienced eczema vaccinatum (EV) and a group of subjects who did not suffer from EV (normal controls or healthy AD subjects).
aggregation:
instance of dataset
refinement:
2 - Complete set of descriptive data and results, as ascertained by ImmPort.
availability:
available with registration
isAbout:
To measure Vaccinia antibody titers and T cell responses in subjects who experienced EV and a group of subjects who did not suffer from EV (NA controls or AD subjects).
clinical trial: clinical trial
study category: Atopy/Allergy
study type: Observational
subject species: Homo sapiens
biosample type: Other
subject gender: Both
assay type:
name:
Atopic Dermatitis Eczema Vaccinatum
fullName:
Donald Leung
affiliations:
National Jewish Health
roles:
principal investigator
name:
ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy
size:
90
name:
Atopic Dermatitis & Vaccinia Network (ADVN) Clinical Studies Consortium
output:
Total antibodies (ELISA) Total vaccinia-specific antibodies (ELISA) Neutralizing antiviral serum vaccinia-specific antibodies (plaque reduction assay) Vaccinia-specific memory B-cells (limiting dilution analysis) IFNγ production by vaccinia-specific CD4+ T cells IFNγ production by vaccinia-specific CD8+ T cells IFNγ production by vaccinia-specific NK T cells CD3 cytokine responses from Memory T cells (Pos Control) Antigen specific antibody levels: diphtheria Antigen specific antibody levels: tetanus Antigen specific antibody levels: pertussis Antigen specific antibody levels: measles Antigen specific antibody levels: mumps Antigen specific antibody levels: rubella Antigen specific antibody levels: polio Antigen specific antibody levels: varicella Antigen specific antibody levels: Epstein-Barr Antigen specific antibody levels: cytomegalovirus Total IgE
studyGroups:
AD+ EV+ with vaccination: Atopic Dermatitis subjects with previous or current EV eczema vaccinatum after smallpox vaccination.
AD+ EV- with vaccination: Atopic Dermatitis subjects with no EV after smallpox vaccination.
Healthy controls with vaccination: Nonatopic/healthy subjects and no eczema vaccinatum after smallpox vaccination.
AD+ no vaccination: Atopic Dermatitis subjects, no smallpox vaccinations.
description:
To measure total and specific antibody titers and T cell responses in a sample of subjects who experienced eczema vaccinatum (EV) and a group of subjects who did not suffer from EV (normal controls or healthy AD subjects).
identifier:
10.21430/M3G81PA5G7
startDate:
2008-04-01
name:
ImmPort
identifier:
SCR:012804
homePage: http://www.immport.org

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.